Seer (SEER) Research & Development (2020 - 2026)
Seer (SEER) posted quarterly Research & Development of $8.8 million for Q1 2026, down 22.41% year-over-year from $11.4 million in Q1 2025, and down 9.61% quarter-over-quarter from $9.7 million in Q4 2025.
Seer (SEER) Research & Development (2020 - 2026) Analysis & Trends
Seer's Research & Development history runs 7 years deep, the most recent figure standing at $8.8 million for Q1 2026.
- In Q1 2026, Research & Development fell 22.41% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $41.3 million (down 16.79% YoY), while the FY2025 annual figure was $43.9 million, down 13.27% from the prior year.
- Research & Development for Q1 2026 stood at $8.8 million, down from $9.7 million in the prior quarter.
- The five-year high for Research & Development was $14.5 million in Q1 2023, with the low at $8.8 million in Q1 2026.
- The 5-year median for Research & Development is $12.0 million (2025), against an average of $11.9 million.
- The sharpest annual moves came in 2022 and 2025: Research & Development surged 72.35% in 2022, then retreated 22.8% in 2025.
- Seer's Research & Development stood at $12.6 million in 2022, then fell by 11.6% to $11.2 million in 2023, then increased by 13.02% to $12.6 million in 2024, then decreased by 22.8% to $9.7 million in 2025, then decreased by 9.61% to $8.8 million in 2026.
- Business Quant data shows SEER's Research & Development at $8.8 million in Q1 2026, $9.7 million in Q4 2025, and $10.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 8.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.21 Mn |
| Mar 31, 2026 | 8.81 Mn |
| Dec 31, 2025 | 9.74 Mn |
| Sep 30, 2025 | 10.80 Mn |
| Jun 30, 2025 | 11.99 Mn |
| Mar 31, 2025 | 11.35 Mn |
| Dec 31, 2024 | 12.62 Mn |
| Sep 30, 2024 | 12.97 Mn |
| Jun 30, 2024 | 12.73 Mn |
| Mar 31, 2024 | 12.27 Mn |
| Dec 31, 2023 | 11.17 Mn |
| Sep 30, 2023 | 13.23 Mn |
| Jun 30, 2023 | 14.15 Mn |
| Mar 31, 2023 | 14.47 Mn |
| Dec 31, 2022 | 12.63 Mn |
| Sep 30, 2022 | 11.56 Mn |
| Jun 30, 2022 | 10.87 Mn |
| Mar 31, 2022 | 10.73 Mn |
| Dec 31, 2021 | 8.22 Mn |
| Sep 30, 2021 | 7.75 Mn |